We've found
2,200 HIV / AIDS
clinical trials
HIV INfections Clinical Trial
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Long-Acting Cabotegravir Plus VRC01LS for Viral Suppression in Adults Living With HIV-1
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Long-Acting Cabotegravir Plus VRC01LS for Viral Suppression in Adults Living With HIV-1
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
A Mobile Gaming App to Improve ART Adherence for Youth
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
HIV/AIDS Clinical Trial
Impact of Physical Activity and Diet on Symptom Experience in People Living With HIV
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in HIV-1-infected Participants on Suppressive cART
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Effect of Methamphetamine on Residual Latent HIV Disease Study
Status: Upcoming,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Consent for Use of Stored Patient Specimens for Future Testing
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Consent for Use of Stored Patient Specimens for Future Testing
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
Primary Immune Deficiency Clinical Trial
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Ophthalmology, Other, Reproductive Clinical Trial
Natural History Study of SCID Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling,
Phase
III
Updated: 11/5/2014
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling,
Phase
III
Updated: 11/5/2014
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling,
Phase
III
Updated: 11/5/2014
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling,
Phase
III
Updated: 11/5/2014
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling,
Phase
III
Updated: 11/5/2014
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV/AIDS Clinical Trial
Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling,
Phase
III
Updated: 3/9/2016
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling,
Phase
III
Updated: 3/9/2016
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling,
Phase
III
Updated: 3/9/2016
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling,
Phase
III
Updated: 3/9/2016
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling,
Phase
III
Updated: 3/9/2016
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling,
Phase
III
Updated: 3/9/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Early Infant HIV Treatment in Botswana
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling,
Phase
III
Updated: 7/26/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling,
Phase
III
Updated: 7/26/2016
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Infection Clinical Trial
A Study to Evaluate the Effects of Multiple Doses of MK-1439 (Doravirine) on Pharmacokinetics of Methadone in Participants Requiring Methadone Maintenance Therapy (MK-1439-045)
Status: Enrolling,
Phase
I
Updated: 3/30/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV Clinical Trial
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV Clinical Trial
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
NC Young Women's CoOp
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Humoral Immune Response Clinical Trial
Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16
Status: Enrolling,
Phase
IV
Updated: 2/21/2018
Click here to add this to my saved trials
Humoral Immune Response Clinical Trial
Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16
Status: Enrolling,
Phase
IV
Updated: 2/21/2018
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Immunologic Deficiency Syndromes Clinical Trial
Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Status: Enrolling,
Phase
III
Updated: 11/21/2017
Click here to add this to my saved trials
HIV INfections Clinical Trial
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Health and Justice: A Continuum of Care for HIV and SU for Justice-Involved Young Adults (PHASE 2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Disorders Clinical Trial
The Mechanistic Biology of Primary Immunodeficiency Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV Clinical Trial
HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Disease Clinical Trial
Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
2,200 HIV / AIDS
clinical trials
HIV INfections Clinical Trial
Updated: 12/31/1969
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Long-Acting Cabotegravir Plus VRC01LS for Viral Suppression in Adults Living With HIV-1
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Long-Acting Cabotegravir Plus VRC01LS for Viral Suppression in Adults Living With HIV-1
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Mobile Gaming App to Improve ART Adherence for Youth
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
HIV/AIDS Clinical Trial
Updated: 12/31/1969
Impact of Physical Activity and Diet on Symptom Experience in People Living With HIV
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in HIV-1-infected Participants on Suppressive cART
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Effect of Methamphetamine on Residual Latent HIV Disease Study
Status: Upcoming,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Consent for Use of Stored Patient Specimens for Future Testing
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Consent for Use of Stored Patient Specimens for Future Testing
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
Primary Immune Deficiency Clinical Trial
Updated: 12/31/1969
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
Updated: 12/31/1969
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
Updated: 12/31/1969
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Ophthalmology, Other, Reproductive Clinical Trial
Updated: 12/31/1969
Natural History Study of SCID Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 8/16/2012
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 8/16/2012
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 8/16/2012
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 8/16/2012
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
HIV Infection Clinical Trial
Updated: 11/5/2014
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling,
Phase
III
Updated: 11/5/2014
Click here to add this to my saved trials
HIV Infection Clinical Trial
Updated: 11/5/2014
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling,
Phase
III
Updated: 11/5/2014
Click here to add this to my saved trials
HIV Infection Clinical Trial
Updated: 11/5/2014
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling,
Phase
III
Updated: 11/5/2014
Click here to add this to my saved trials
HIV Infection Clinical Trial
Updated: 11/5/2014
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling,
Phase
III
Updated: 11/5/2014
Click here to add this to my saved trials
HIV Infection Clinical Trial
Updated: 11/5/2014
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling,
Phase
III
Updated: 11/5/2014
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV/AIDS Clinical Trial
Updated: 12/31/1969
Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV-1 Clinical Trial
Updated: 10/28/2015
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Updated: 10/28/2015
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Updated: 10/28/2015
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Updated: 10/28/2015
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Updated: 10/28/2015
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Updated: 10/28/2015
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
HIV-1 Clinical Trial
Updated: 10/28/2015
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling,
Phase
III
Updated: 10/28/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Updated: 3/9/2016
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling,
Phase
III
Updated: 3/9/2016
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Updated: 3/9/2016
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling,
Phase
III
Updated: 3/9/2016
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Updated: 3/9/2016
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling,
Phase
III
Updated: 3/9/2016
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Updated: 3/9/2016
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling,
Phase
III
Updated: 3/9/2016
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Updated: 3/9/2016
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling,
Phase
III
Updated: 3/9/2016
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Updated: 3/9/2016
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling,
Phase
III
Updated: 3/9/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Early Infant HIV Treatment in Botswana
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 7/26/2016
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling,
Phase
III
Updated: 7/26/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 7/26/2016
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling,
Phase
III
Updated: 7/26/2016
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Infection Clinical Trial
Updated: 3/30/2016
A Study to Evaluate the Effects of Multiple Doses of MK-1439 (Doravirine) on Pharmacokinetics of Methadone in Participants Requiring Methadone Maintenance Therapy (MK-1439-045)
Status: Enrolling,
Phase
I
Updated: 3/30/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Updated: 12/31/1969
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Updated: 12/31/1969
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Updated: 12/31/1969
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV Clinical Trial
Updated: 12/31/1969
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV Clinical Trial
Updated: 12/31/1969
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
NC Young Women's CoOp
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Humoral Immune Response Clinical Trial
Updated: 2/21/2018
Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16
Status: Enrolling,
Phase
IV
Updated: 2/21/2018
Click here to add this to my saved trials
Humoral Immune Response Clinical Trial
Updated: 2/21/2018
Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16
Status: Enrolling,
Phase
IV
Updated: 2/21/2018
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
Updated: 12/31/1969
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Immunologic Deficiency Syndromes Clinical Trial
Updated: 11/21/2017
Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Status: Enrolling,
Phase
III
Updated: 11/21/2017
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Health and Justice: A Continuum of Care for HIV and SU for Justice-Involved Young Adults (PHASE 2)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Disorders Clinical Trial
Updated: 12/31/1969
The Mechanistic Biology of Primary Immunodeficiency Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV Clinical Trial
Updated: 12/31/1969
HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Disease Clinical Trial
Updated: 12/31/1969
Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials